Vortioxetine Hydrobromide | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Vortioxetine Hydrobromide
U.S. EXCLUSIVITIES

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Metrochem Vortioxetine Hydrobromide

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Vortioxetine Hydrobromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 24 USDMF, 3 JDMF, 5 EU WC, 9 KDMF, 8 NDC API, 30 Listed Suppliers, $ API Reference Price

45 API Suppliers
24 USDMF
3 JDMF
5 EU WC
9 KDMF
8 NDC API
30 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

9 Intermediates Suppliers

9 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers, 18 FDA Orange Book, 30 Europe, 3 Canada, 15 South Africa, 13 Listed Dossiers

79 FDF Dossiers
18 FDA Orange Book
30 Europe
3 Canada
15 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE
TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 2 DKSH, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 5 Kerry, 9 Microlex e.U, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Vasa Pharmachem

1 Rochem International Inc
13 SPI Pharma
2 DKSH
7 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
1 Clariant
3 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
2 Ingredion Pharma Solutions
5 Kerry
9 Microlex e.U
2 Pharmatrans-Sanaq
2 Pluviaendo
3 Prachin Chemical
14 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
9 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 22 Direct Compression, 14 Disintegrants & Superdisintegrants, 13 Thickeners and Stabilizers, 11 Taste Masking, 11 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 11 Co-Processed Excipients, 9 Granulation, 8 Coating Systems & Additives, 5 Parenteral, 4 Film Formers & Plasticizers, 4 Controlled & Modified Release, 2 Topical, 2 Coloring Agents, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents

37 Fillers, Diluents & Binders
22 Direct Compression
14 Disintegrants & Superdisintegrants
13 Thickeners and Stabilizers
11 Taste Masking
11 Lubricants & Glidants
11 Chewable & Orodispersible Aids
11 Co-Processed Excipients
9 Granulation
8 Coating Systems & Additives
5 Parenteral
4 Film Formers & Plasticizers
4 Controlled & Modified Release
2 Topical
2 Coloring Agents
2 Rheology Modifiers
1 API Stability Enhancers
1 Surfactant & Foaming Agents
1 Emulsifying Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 44 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
44 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Finished Drug Prices, 17 Annual Reports

1 US Medicaid Prescriptions
25 Finished Drug Prices
17 Annual Reports

MARKET PLACE

8 APIs, 4 FDF Dossiers, 1 Intermediates

8 APIs
4 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

80 US Patents, 12 US Exclusivities, 12 Health Canada Patents

80 US Patents
12 US Exclusivities
12 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 Others

7 Others

$ API Ref.Price (USD/KG) : 3,478 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

12 All

01 12TAKEDA PHARMS USA

filter Product Reset all filters

12 All

01 12VORTIOXETINE HYDROBROMIDE

filter Exclusivity Expiration Date Reset all filters

12 All

01 42024-01-22

02 42026-08-23

03 42027-02-23

filter Exclusivity Code Reset all filters

12 All

01 4M-187

02 4M-232

03 4PED

Product Main Page

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-232

Exclusivity Expiration Date

2026-08-23

Application Number

204447

Product Number

2

Exclusivity Details

01

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2026-08-23

Application Number : 204447

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

PED

Exclusivity Expiration Date

2027-02-23

Application Number

204447

Product Number

2

Exclusivity Details

02

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-02-23

Application Number : 204447

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-187

Exclusivity Expiration Date

2024-01-22

Application Number

204447

Product Number

2

Exclusivity Details

03

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-187

Exclusivity Expiration Date : 2024-01-22

Application Number : 204447

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

PED

Exclusivity Expiration Date

2027-02-23

Application Number

204447

Product Number

1

Exclusivity Details

04

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-02-23

Application Number : 204447

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-232

Exclusivity Expiration Date

2026-08-23

Application Number

204447

Product Number

4

Exclusivity Details

05

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2026-08-23

Application Number : 204447

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-187

Exclusivity Expiration Date

2024-01-22

Application Number

204447

Product Number

4

Exclusivity Details

06

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-187

Exclusivity Expiration Date : 2024-01-22

Application Number : 204447

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-232

Exclusivity Expiration Date

2026-08-23

Application Number

204447

Product Number

3

Exclusivity Details

07

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2026-08-23

Application Number : 204447

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-187

Exclusivity Expiration Date

2024-01-22

Application Number

204447

Product Number

3

Exclusivity Details

08

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-187

Exclusivity Expiration Date : 2024-01-22

Application Number : 204447

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-232

Exclusivity Expiration Date

2026-08-23

Application Number

204447

Product Number

1

Exclusivity Details

09

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2026-08-23

Application Number : 204447

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

VORTIOXETINE HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

M-187

Exclusivity Expiration Date

2024-01-22

Application Number

204447

Product Number

1

Exclusivity Details

10

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

VORTIOXETINE HYDROBROMIDE

Exclusivity Code : M-187

Exclusivity Expiration Date : 2024-01-22

Application Number : 204447

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?